nivolumab
bms
['checkmate 816', 'check,mate,816', 'lcsm,(-blcsm)']
strong correlation between pcr and dfs regardless of ln status. 92% dfs rate at 2 years. pathology analysis from checkmate 816. #esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm